124
Views
6
CrossRef citations to date
0
Altmetric
Research Article

2D QSAR studies on a series of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one as CETP inhibitors

, &
Pages 423-438 | Received 16 Mar 2020, Accepted 02 May 2020, Published online: 01 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, Paul Andrew Mamza, Muhammad Tukur Ibrahim, Anshuman Chandra & Vijay Kumar Goel. Molecular modelling studies of substituted indole derivatives as novel influenza a virus inhibitors. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now

Articles from other publishers (5)

Shelly Pathania, Kseniia Petrova-Szczasiuk, Olli Pentikäinen & Pankaj Kumar Singh. (2023) Oxazolidinones: Are they only good for the discovery of antibiotics? A worm's eye view. Journal of Molecular Structure 1286, pages 135630.
Crossref
Kirishnamaline Gomathishankkar, Daisy Magdaline Joseph Yesudian, Chithambarathanu Thiraviam & Ronaldo Anuf Alexander. (2022) Quantum chemical evaluation, QSAR analysis, molecular docking and dynamics investigation of s-triazine derivatives as potential anticancer agents. Structural Chemistry 33:6, pages 2083-2113.
Crossref
Tengyi Zhu, Cuicui Tao, Haomiao Cheng & Haibing Cong. (2022) Versatile in silico modelling of microplastics adsorption capacity in aqueous environment based on molecular descriptor and machine learning. Science of The Total Environment 846, pages 157455.
Crossref
Víctor Gallego, Roi Naveiro, Carlos Roca, David Ríos Insua & Nuria E. Campillo. (2021) AI in drug development: a multidisciplinary perspective. Molecular Diversity 25:3, pages 1461-1479.
Crossref
Alya A Arabi. (2021) Artificial intelligence in drug design: algorithms, applications, challenges and ethics. Future Drug Discovery 3:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.